Breaking News
BNTX Stock Price | BioNTech SE ADR Stock Quote (U.S.: Nasdaq) | MarketWatch
[ad_1]
BioNTech SE ADR
BioNTech SE engages in the development of novel medicines at the intersection of immunology and synthetic biology. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
[ad_2]
